NCM · Financial Statements
Outlook Therapeutics, Inc. (OTLK) Financial Statements
$0.57
NCM: OTLK
Market Cap $107.07M
Overview Financials Dividend Outlook Therapeutics, Inc. most recently reported annual revenue of $1.0M, net profit of $-62.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $0 $1.0M Operating Profit $-52.0M $-63.0M $-53.0M $-72.0M $-67.0M Net Profit $-53.0M $-66.0M $-59.0M $-75.0M $-62.0M EPS $-7.00 $-6.23 $-4.80 $-4.06 $-1.79 Op Margin — — — — -4744.3%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $23.0M $29.0M $32.0M $29.0M $19.0M Total Liabilities $18.0M $20.0M $47.0M $102.0M $51.0M Cash $14.0M $17.0M $23.0M $15.0M $8.0M Borrowings $12.0M $11.0M $36.0M $30.0M $30.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-54.0M $-57.0M $-43.0M $-69.0M $-52.0M Investing Cash Flow $0 $0 $0 $0 $0 Financing Cash Flow $4.0M $0 $-1.0M $0 $0 Net Cash Flow $2.0M $3.0M $6.0M $-8.0M $-7.0M Free Cash Flow $-54.0M $-57.0M $-43.0M $-69.0M $-52.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -1.89 FCF Yield -51.78% Quick Ratio 0.63 Interest Coverage -210.62 Return 1Y -30.84% Return 3Y -95.24% Return 5Y -96.50%
Screens featuring this stock